CSBR Champion’s OncologyChampions seems to be setting up for a potential pump into the Fibonacci channel. If so, look for $60. I’ve been watching IBB for a long time, and thought it would fall out, but it’s looks strong, so I’m expecting breakouts in a number of tickers.Longby Shammus010
For now a buy order!!! at 4,6 Buy 5,09 Take profit 9,8 Stoploss Below the latest low It will take a while for huge bullrun Longby G1D3onn0
Champion’s OncologyIf and once we revisit the .236 fib channel level, a buy is triggered, and you want to sell into the .618 to .786 zone.Longby Shammus010
$CSBREntry price : 11.52 Fundamentals : - Sector: Medical - EPS % Chg (Last Qtr): 140% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 42% - 3-Year Sales Growth Rate: 28% - Annual Pre -Tax Margin: -3.9% Longby paulopicaocapeloUpdated 111
CSBR Reversal CandlesHas seen reversal candles for several straight days on daily chart including Monday's on high volume. Monday's close was above 20-day moving average too. Looks like this might be getting ready to make a run and test resistance at $10. Longby Breakout_Trade0
CSBR: A silent winnerCSBR has broken out of its wedge a while back but hasn't done much since. I think it is gearing up for its next move higher. I would watch for a test of the trendline and look to accumulate there where I expect the stock to begin its next launch to new highs.Longby torquioUpdated 113
CSBRChampions Oncology Inc. (CSBR) develops novel technologies for oncology diagnosis and treatment. It topped out at $23.88 in 2013 and entered a decline that posted an all-time low at $1.11 in August 2016. A basing pattern into November got bought, lifting the stock into a recovery wave that broke out above the 200-day EMA in January 2017. It topped out and rolled over at the start of February, with the decline now positioned a few cents above moving average support. Look for committed buyers to take a stand here, ahead of a bounce that could new 2017 highs. by Investopedia4